Daiwa Securities Group
IRON icon

Daiwa Securities Group’s Disc Medicine IRON Stock Holding History

Daiwa Securities Group’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-113
Closed -$9K – 1309
2025
Q4 		$9K Hold
113
– – ﹤0.01% 1192
2025
Q3 		$7K Hold
113
– – ﹤0.01% 1183
2025
Q2 		$6K Hold
113
– – ﹤0.01% 1148
2025
Q1 		$6K Hold
113
– – ﹤0.01% 1123
2024
Q4 		$7K Hold
113
– – ﹤0.01% 1147
2024
Q3 		$6K Buy
113
+54
+92% +$2.54K ﹤0.01% 1157
2024
Q2 		$3K Sell
59
-40
-40% -$1.36K ﹤0.01% 1230
2024
Q1 		$6K Hold
99
– – ﹤0.01% 1195
2023
Q4 		$6K Buy
+99
New +$5.07K ﹤0.01% 1193

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Daiwa Securities Group's IRON Position: Q1 2026 in Review

Daiwa Securities Group sold out of Disc Medicine (IRON) in Q1 2026, closing a stake of 113 shares — an estimated $9K sold.

Daiwa Securities Group first reported a position in IRON in Q4 2023 and held it in 9 quarters. The position peaked at $9K in Q4 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Daiwa Securities Group reported no remaining Disc Medicine position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 113 Disc Medicine shares in Q1 2026, an estimated $9K.
  • Daiwa Securities Group first reported a position in Disc Medicine in Q4 2023 and held it in 9 quarters.
  • Daiwa Securities Group's Disc Medicine position peaked at $9K in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.